Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2002

01-01-2002 | Case Report

Establishment of a Monosomy 7 Leukemia Cell Line, MONO-7, With aras Gene Mutation

Authors: Hiroyuki Fujisaki, Kenji Takai, Akihisa Sawada, Sadao Tokimasa, Yoshiko Matsuda, Hideaki Ohta, Yuko Osugi, Ji Yoo Kim, Gaku Hosoi, Masahiro Sako, Junichi Hara

Published in: International Journal of Hematology | Issue 1/2002

Login to get access
Metadata
Title
Establishment of a Monosomy 7 Leukemia Cell Line, MONO-7, With aras Gene Mutation
Authors
Hiroyuki Fujisaki
Kenji Takai
Akihisa Sawada
Sadao Tokimasa
Yoshiko Matsuda
Hideaki Ohta
Yuko Osugi
Ji Yoo Kim
Gaku Hosoi
Masahiro Sako
Junichi Hara
Publication date
01-01-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02981983

Other articles of this Issue 1/2002

International Journal of Hematology 1/2002 Go to the issue

Letter to the Editor

Toxoplasmic Encephalitis in a Non-HIV Patient With Follicular Lymphoma

Case Report

Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule

Letter to the Editor

Secondary Acute Promyelocytic Leukemia in a Patient With Non-Hodgkin’s Lymphoma Treated With VP-16 and MST-16

OriginalPaper

Detection of CD55- and/or CD59-Deficient Red Cell Populations in Patients With Plasma Cell Dyscrasias

Case Report

Constitutive Activation of Stat1 and Stat3 in Primary Erythroleukemia Cells

Editorial

Renaissance of theInternational Journal of Hematology
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits